A Study of LY2922470 in Healthy Participants and Participants With Diabetes

NCT01746017 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

26

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Placebo
DRUG: LY2922470

Sponsor

Eli Lilly and Company